期刊文献+

比索洛尔联合曲美他嗪对慢性心力衰竭患者心功能康复的影响 被引量:1

The effect of bisoprolol combined with trimetazidine on the rehabilitation of heart function in patients with chronic heart failure
下载PDF
导出
摘要 目的:探讨比索洛尔联合曲美他嗪对慢性心力衰竭患者心功能康复的影响。方法:2017年12月-2018年1月收治慢性心力衰竭患者72例,随机分为两组,各36例。对照组采用常规药物治疗,试验组在常规药物治疗的基础上采用比索洛尔联合曲美他嗪治疗。比较两组治疗效果和心功能康复情况。结果:试验组治疗效果和心功能康复情况优于对照组;差异有统计学意义(P<0.05)。结论:在常规治疗的基础上采用比索洛尔联合曲美他嗪治疗慢性心力衰竭患者,治疗效果明显提高,同时心功能得到有效的康复。 Objective:To explore the effect of bisoprolol combined with trimetazidine on the rehabilitation of heart function in patients with chronic heart failure.Methods:From December 2017 to January 2018,72 patients with chronic heart failure were treated,they were randomly divided into the two groups with 36 cases in each group.The control group was treated with conventional drugs.The experimental group was treated with bisoprolol and trimetazidine on the basis of conventional drugs.The therapeutic effect and cardiac rehabilitation were compared between the two groups.Results:The therapeutic effect and cardiac function recovery of the experimental group were better than that of the control group,the difference was statistically significant(P<0.05).Conclusion:On the basis of routine treatment,bisoprolol combined with trimetazidine can significantly improve the therapeutic effect and effectively recover the cardiac function in patients with chronic heart failure.
作者 沈芳 徐樱 李玮 Shen Fang;Xu Ying;Li Wei(The Third Hospital of Changsha City,Hunan Province,Hunan Changsha 410015)
出处 《中国社区医师》 2020年第17期55-56,共2页 Chinese Community Doctors
关键词 比索洛尔 曲美他嗪 慢性心力衰竭 心功能 Bisoprolol Trimetazidine Chronic heart failure Cardiac function
  • 相关文献

参考文献4

二级参考文献56

  • 1滕尧文.曲美他嗪治疗不稳定型心绞痛的疗效评价[J].中国心血管病研究,2005,3(3):212-213. 被引量:31
  • 2刘全,程莉,杨洋.冠状动脉内皮细胞在缺血再灌注损伤时的变化和曲美他嗪的保护作用[J].中华老年医学杂志,2006,25(1):71-73. 被引量:16
  • 3新谦.新药治疗研究指导原则[M].北京:人民卫生出版社,1994:217-218.
  • 4Smilde TDJ,van D J,van den Berg MP.Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure[J].Clin Res Cardiol,2009,98(4):233-239.
  • 5Abozguia K,Shivu GN,Ahmed I.The metabolic treatment of coronary artery disease and heart failure[J].Curr Pharm Des,2009,15 (8):8261.
  • 6Khazanov VA,Kiseliova AA,Vasiliev KY,et al.Cardioprotective effects of trimetazidine and a combination of succinic and malic acids in acute myocardial ischemia[J].Bull Exp Biol Med,2008,146(2):218-221.
  • 7Slart RH,Tio RA,van der Vleuten PA,et al.Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy[J].J Nucl Cardiol,2010,17 (3):479-485.
  • 8Bittencourt MI,Benchimol-Barbosa PR,Drumond Neto C,et al.Assessing autonomic function in hypertrophic cardiomyopathy[J].Arq Bras Cardiol,2005,85(6):388-396.
  • 9Aukrust P, Yndestad A, Dmas JK, et al. Therapeutic potential of anticytokine therapy in congestive heart failure. Am J Cardio- vasc Drugs, 2004,4 : 169-177.
  • 10Zaca V, Rastogi S, Imai M, et al. Chronic monotherapy with ro- suvastatin prevents progressive left ventricular dysfunction and re- modeling in dogs with heart failure. J Am Coll Cardiol, 2007,50: 551-557.

共引文献63

同被引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部